Re: DEC/oxibendazole article

http://www.merckvetmanual.com/digestive-system/hepatic-disease-in-small-animals/hepatotoxins-in-small-animals Chronic oxibendazole-diethylcarbamazine administration in dogs was shown to cause increased ALT and ALP activity, hyperbilirubinemia, periportal hepatitis, and fibrosis. Progressive injury and clinical signs resolved in many but not all dogs after drug discontinuation.